Raoult et Gautret on resistance aux antibiotics.

HCQ+AZ, the pre-therapy workup and the follow-up: electrolytes, electrocardiogram with corrected QT (Bazett’s formula) and more.

There are some contra-indications for the HCQ+AZ treatment. Also, patients need to be screened for potential prolongation of QT time on electrocardiogram and for electrolyte balance. Given that the IHU hospital in Marseille, France, is a pole of excellence, we recommend using their pre-therapy workup and the follow-up recommendations.

People are queuing to be tested for SARS-CoV-2 in the IHU Marseille of Didier Raoult. There is a high risk of getting infected in this situation. Staying in the cold also reduces innate immunity.

A test: Calculate the in-hospital mortality in the patients that did not receive either hydroxychloroquine or azithromycin in Marseille, France.

To find out if hydroxychloroquine plus azithromycin (HCQ+AZ), the preferred treatment at the IHU hospital in Marseille, France, is effective, we need to calculate the in-hospital mortality in patients who did receive HCQ+AZ and in patients who didn’t.

Virologist Dorothee von Laer, director of the Institute of Virology at the Medical University of Innsbruck, with colleagues. Von Laer is one of the authors of the SARS-CoV-2 seropositivity study in Ischgl.

42% seroprevalence for SARS-CoV-2 in an Austrian town. A majority of seropositives reported taste and smell disorders.

The loss of smell is an important sign of COVID-19 infection. It is reported in a majority of younger patients and it can be lasting.
Didier Raoult: “30% have NOT recovered their sense of smell yet.”

French infectious disease specialist Didier Raoult presented a rapport to the French Senate in 2012 and talked about flu, SARS, antibiotics and viral infections.

Raoult on flu, antibiotics and viral infections in the French Senate in 2012.

We made a note of several interesting remarks that Didier Raoult, professor of microbiology and infectious disease, made in a presentation to members of the French Senate in 2012.

Mediterrannee Infections is a large infectious disease hospital network in the area of the city of Marseille.

Treatment of COVID-19 in Marseille, France.

No corticosteroids. Anticoagulants only for severe cases.
In a cohort of relatively young patients (mean age 43,6 years, standard deviation 15.6 years), the use of antihypertensive drugs was the only independent strong predictor of poor outcomes. The age was a weak independent predictor of poor outcomes .

Didier Raoult, the head of a center for infectious disease in Marseille, France, on the current "standards of care" for the treatment of COVID-19: "you can't tell COVID-19 patients "stay at home, and when you can't breathe anymore, come to the hospital to die".

The current “standards of care” for the treatment of COVID-19: “stay at home, and when you can’t breathe anymore, come to the hospital to die”.

Didier Raoult, who is the head of a center for infectious disease in Marseille, France, summed up what is de facto “the standards of care” for COVID-19.

Didier Raoult: “We did not test antibiotics against viruses. Now we do and we realize that a lot of antibiotics are effective against viruses.”

The notion that antibiotics are not effective against viruses has been pounded a lot. However, this notion may not be true.

The New Neander's Medical on December 14, 2020: Astra Zeneca's large trial gives us an idea of what percentage of SARS-CoV-2 infections are asymptomatic. In the control arm of COV002 group that did weekly swabs, the proportion of asymptomatic cases was 1.2%/(1.2%+1.8%)=40%.

What proportion of SARS-CoV-2 infections are asymptomatic?

Asympotomatic SARS-CoV-2 infections accounted for 40% of all SARS-CoV-2 infections in the control arm of Astra Zeneca-Oxford vaccine trial that did weekly swabs.